Arvinas logo

Outcomes in men with metastatic castration-resistant prostate cancer and tumors with certain androgen receptor (AR) mutations

Tyler F. Stewart, et al.

September 9, 2022
European Society for Medical Oncology (ESMO)
Skip to content